New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for isolated dystonia and for Parkinson’s diseaseFirst ...

New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for ...

US biotech Vima Therapeutics has secured $40 million in a series A extension to support development of its oral movement-disorder therapy VIM0423, bringing the total financing round to $100 million.

Unhealthy weight loss can cause more health problems than you might think. A doctor shared ten signs you should be aware of, including brittle nails, hair fall, muscle cramps, and more.

Image in Creative Commons. In 1967, Hungarian scientist Endre Mester tried to cure skin cancer in mice using a low-powered ruby laser. He failed to stop ...

Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory ...

We spoke with experts to craft a research-backed blueprint to build sleeve-splitting biceps and triceps ...

PGN-EDODM1, an experimental DM1 therapy from Pepgen, showed biomarker activity and splicing correction in an early clinical ...

People with BMD who received sevasemten in clinical trials maintained stable motor function over several years of follow-up, new data show.

Loose skin after weight loss isn't permanent. These science-backed methods help your skin bounce back faster, look firmer, and regain elasticity you thought was gone.

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.

Hello, and welcome to the Protara Therapeutics ASCO GU Update Call. [Operator Instructions] As a reminder, this conference call is being recorded. If you have any objections, please disconnect at this ...